Chemoinformaics analysis of N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-9-METHYLDECANAMIDE
| Molecular Weight | 321.461 | nRot | 11 |
| Heavy Atom Molecular Weight | 290.213 | nRig | 1 |
| Exact Molecular Weight | 321.23 | nRing | 1 |
| Solubility: LogS | -1.921 | nHRing | 0 |
| Solubility: LogP | 2.264 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 55.9066 |
| nHD | 2 | BPOL | 34.2734 |
| QED | 0.544 |
| Synth | 1.841 |
| Natural Product Likeliness | -0.204 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.015 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.212 |
| MDCK | 0.0000376 |
| BBB | 0.994 |
| PPB | 0.624577 |
| VDSS | 0.803 |
| FU | 0.486084 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.323 |
| CYP2c19-inh | 0.334 |
| CYP2c19-sub | 0.676 |
| CYP2c9-inh | 0.334 |
| CYP2c9-sub | 0.698 |
| CYP2d6-inh | 0.028 |
| CYP2d6-sub | 0.066 |
| CYP3a4-inh | 0.017 |
| CYP3a4-sub | 0.242 |
| CL | 11.343 |
| T12 | 0.877 |
| hERG | 0.008 |
| Ames | 0.012 |
| ROA | 0.027 |
| SkinSen | 0.585 |
| Carcinogencity | 0.193 |
| EI | 0.988 |
| Respiratory | 0.05 |
| NR-Aromatase | 0.004 |
| Antiviral | Yes |
| Prediction | 0.696267 |